MEDVi vs WeightWatchers Clinic (2026): prices, structure, verdict

On tirzepatide, only MEDVi↗ has a rankable figure: $399 a month all-in; WeightWatchers Clinic↗ routes tirzepatide through brand channels without a single compounded cash price — its cost depends on coverage or the manufacturer programs (Zepbound vials $299–$449; Wegovy $349).

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, only MEDVi has a rankable figure: $299 a month all-in; WeightWatchers Clinic routes semaglutide through brand channels without a single compounded cash price — its cost depends on coverage or the manufacturer programs (Zepbound vials $299–$449; Wegovy $349).

§ Side by side

§ Each record, read aloud

The two records, condensed

MEDVi: the record, condensed

MEDVi’s tirzepatide program bills $399 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $399 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #14 of 17 in the verified tirzepatide index — $184/month above the floor (NexLife↗, $215) — and sits $50 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $4,788.

Start with the load-bearing figure: $299 a month, all-in, is what MEDVi charges for semaglutide at the 2.4 mg basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.

To place the number: #18 of 20 verified programs, with the floor $166/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $50 a month. A year at this figure: $3,588 monthly-billed.

Operationally at MEDVi: shipping included; commitment 12-month plan for the lowest rate; cancellation 12-month plan applies to lowest rate; pharmacy not publicly named — ask in writing before paying; states: priced differently in CA/NC on some plans; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the MEDVi page · visit MEDVi ↗

WeightWatchers Clinic: the record, condensed

On tirzepatide, WeightWatchers Clinic is a brand channel rather than a priced product: it prescribes the FDA-approved medication, and what you pay depends on coverage or the manufacturer cash programs (Zepbound (LillyDirect) at $299–$449).

WeightWatchers Clinic routes semaglutide through brand product — no single compounded cash figure exists to rank. The reference prices live one layer down: Wegovy (NovoCare), $199–$349 a month cash, or whatever your insurance turns those numbers into.

Operationally at WeightWatchers Clinic: shipping per pharmacy; commitment membership recurs monthly; cancellation membership recurs until cancelled; pharmacy named (brand fulfillment; NovoCare partner pricing); states: most states; evidence no public price, captured 2026-08-05. The full record with source and archive links: the WeightWatchers Clinic page · visit WeightWatchers Clinic ↗

§ Structure vs structure

Everything besides the price

Coverage: MEDVi publishes “priced differently in CA/NC on some plans”; WeightWatchers Clinic publishes “most states” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: WeightWatchers Clinic names its network (brand fulfillment; NovoCare partner pricing); MEDVi does not, which shifts the burden of verification onto your intake questions.

Exit terms: MEDVi — 12-month plan for the lowest rate; 12-month plan applies to lowest rate. WeightWatchers Clinic — membership recurs monthly; membership recurs until cancelled.

Insurance: only WeightWatchers Clinic does coverage work — decisive if there is any chance your plan covers a brand GLP-1, because a covered prescription beats both cash paths on this page.

Evidence: MEDVi source-verified (captured 2026-08-05); WeightWatchers Clinic no public price (2026-08-05).

A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.

§ If you move

Switching between MEDVi and WeightWatchers Clinic

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (MEDVi: 12-month plan applies to lowest rate; WeightWatchers Clinic: membership recurs until cancelled) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings